Under the terms of the non-exclusive partnership, Home Service will deliver prescription drugs on behalf of Healthscreen to patients electing for a home delivery option during the diabetes management pilot study.
Justin Belobaba, president and CEO of Healthscreen, said: “Partnering with an established mail-order pharmacy, with the infrastructure, capacity and knowledge required to deliver prescription drugs is integral to the success of our diabetes management program.
“Giving patients the option to have prescription drugs delivered to their doorstep adds another valuable element to the diabetes management program, and we hope to form similar partnerships going forward, as we continue to enhance this service.”